{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-23-000805","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2023-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.768659+00:00","generated_at":"2026-06-19T15:47:28.287963+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Sunshine Biopharma regains Nasdaq minimum bid price compliance","bullets":["Received Staff notice on Feb 9, 2023, confirming compliance with $1 bid price rule.","Regained compliance removes immediate delisting risk from Nasdaq.","Company's common stock (SBFM) and warrants (SBFMW) continue trading on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-23-000805","json":"https://secwatch.observer/filing/0001683168-23-000805.json","markdown":"https://secwatch.observer/filing/0001683168-23-000805.md","text":"https://secwatch.observer/filing/0001683168-23-000805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/0001683168-23-000805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316823000805/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T15:47:28.287963+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}